Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ganaxolone for use in prophylaxis and treatment of postpartum depression

Ganaxolone for use in prophylaxis and treatment of postpartum depression

US Patent 11266662 · Granted Mar 8, 2022

Estimated economic value: $3,842,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Method of treating a blood vessel with multiple shock wave discharge points in a2025
Multiple shock waves catheter2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2025
Ganaxolone for use in treatment of status epilepticus2025
Ganaxolone for use in treatment of status epilepticus2025
Catheter with multiple shock wave generators2025
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders2024
Ganaxolone for use in treating tuberous sclerosis complex2024
Catheter with multiple shock wave generators2024
Ganaxolone for use in treating tuberous sclerosis complex2023